JJET

The pioneer of cardiac electrophysiology in China

JJET has long been deeply engaged in the field of cardiac electrophysiology, dedicated to the research and development, production and sales of high-end innovative diagnostic and ablation medical devices. The quality and performance of its core products are fully on par with those of international leading enterprises. Based on over two decades of research and development, innovation and technological accumulation, the company provides safe and efficient overall diagnosis and treatment solutions for patients with tachyarrhythmia worldwide.

0+ years

Company history

Listed products

Products under research and development

Invention patent (granted)

The electrophysiological business covers hospitals

Learn more...

The future of the pulse era has arrived

NAVABLATOR^®Ablation Catheter and PROMAPPER^®Electrophysiology Catheter Receive NMPA Approval

Learn more...

Jinjiang Catheter Laboratory

A comprehensive and first-class overall electrophysiological solution

以科技呵护生命

Exceeding,innovating and experiencing the beauty of technology together with JJET.
We believe that health is the foundation of quality life.
Technology is the guardian of quality life.
Leading technological innovation and building the bridge of trust, we uphold utmost respect for life in our daily work.

公司大事记

In 2020

Electrophysiology Catheters and Ablation Catheters received NMPA approval.

In 2018

Signed the investment and financing cooperation agreement with Shenzhen Salubris Pharmaceuticals Co., Ltd.

In2015

Electrophysiology Recording System and Cardiac RF Ablation Generator obtained CE certificate.

In2014

Established a joint-venture company- Suzhou Xinmai Medical Equipment Co.,Ltd in Suzhou Industrial Park.

In2013

3D Cardiac Mapping Systerm was approved by China Food and Drug Administration(CFDA).

In2011

Successful acquisition of the America company CARDIMA INC.

In2009

Developed the 3Ding Cardiac Mapping System.

In2007

HL-100G Cardiac RF Ablation Generator entered the international market.

In2004

Set up strategic collaboration with C.R. Bard Inc., an internationally recognized corporation in the cardiac EP field.

In2003

Developed the Hemodynamic Monitoring System with pressure guide wire measurement and analysis function.

In1996

Developed the Full-digital Multichannel EP Management System.

In1991

Developed the Cardiac Radio-frequency Ablation Gnnerator.